Results 221 to 230 of about 148,802 (383)

Predictive Performance of Device‐Neonatal Skin Risk Assessment Scale to Evaluating Pressure Injuries Risk in the Neonates. An Observational Multicenter Study

Journal of Clinical Nursing, EarlyView.
ABSTRACT Aim To assess the validity of a modified Neonatal Skin Risk Assessment scale (Dev‐NSARS) for neonatal pressure injuries (PIs) in the neonatal intensive care unit (NICU) and neonatal sub‐intensive care unit (NICU‐Sub) environment. Background Medical devices are the leading cause of pressure injuries (PIs) in neonates, a key cause of morbidity ...
Biagio Nicolosi, Elisa Neri, Leonardo Fioravanti, Silvia Leoncini, Claudio De Felice, Pablo Garcìa‐Molina, Alessandra Mugnaini   +6 more
wiley   +1 more source

Genetic Evidence of Association Between Gastroesophageal Reflux Disease and Hypertensive Disorders in Pregnancy. [PDF]

JGH Open
Li Q, Pang Y, Yue C, Zhao C, Lei D, Zhou J.   +5 more
europepmc   +1 more source

Patient-centered outcomes of laparoscopic nissen fundoplication for gastroesophageal reflux disease

, 2000
Liane S. Feldman, Serge Mayrand, Maureen Antoniuk, Gerald M. Fried   +3 more
openalex   +1 more source

Use of dipeptidyl peptidase‐4 inhibitors is associated with lower risk of severe renal outcomes in pre‐dialysis patients with Type 2 diabetes

Journal of Internal Medicine, EarlyView.
Abstract Objectives Patients with diabetes and Stage 5 chronic kidney disease (CKD) not on dialysis are susceptible to renal replacement therapy and severe complications. Among limited antidiabetic options in this vulnerable population, dipeptidyl peptidase‐4 (DPP‐4) inhibitors (DPP‐4i) are widely used; however, supporting evidence is scant.
Tung‐Ying Hung, Tzu‐Chieh Lin, Ying‐Jay Liou, Tzu‐Han Lin, Yu‐Juei Hsu, Liang‐Yu Lin, Meng‐Ting Wang   +6 more
wiley   +1 more source

Childhood gastroesophageal reflux disease: A comprehensive review of disease, diagnosis, and therapeutic management. [PDF]

World J Clin Pediatr
Raza D, Mohiuddin F, Khan MH, Fawad M, Raza SM.   +4 more
europepmc   +1 more source

Usage of supplemental alternative medicine by community-based patients with gastroesophageal reflux disease (GERD)

, 2000
Craig W. Hayden, Neil Shernoff, Raymond E. Moldow, Carl Kanun, Paul Bergreen, Steven L. Palley, Angelo Trujillo, J C Mitrius, Harinder S. Garewal, Ronnie Fass   +9 more
openalex   +1 more source

Updating the Bruxism Definitions: Report of an International Consensus Meeting

Journal of Oral Rehabilitation, EarlyView.
ABSTRACT Background Bruxism is receiving increasing attention from both clinicians and researchers over the past decades. Recently, it has become clear that some aspects of the currently proposed, expert‐driven bruxism definitions raise questions and cause confusion among clinicians, researchers, educators and patients.
Merel C. Verhoeff, Frank Lobbezoo, Jari Ahlberg, Steven Bender, Alessandro Bracci, Anna Colonna, Cibele Dal Fabbro, Justin Durham, Alan G. Glaros, Birgitta Häggman‐Henrikson, Takafumi Kato, Michail Koutris, Gilles J. Lavigne, Laura Nykänen, Karen G. Raphael, Peter Svensson, Mieszko Wieckiewicz, Daniele Manfredini   +17 more
wiley   +1 more source

Antireflux mucosal intervention for refractory gastroesophageal reflux disease after multiple Nissen fundoplications. [PDF]

Endoscopy
Saino M, Inoue H, Ushikubo K, Yamamoto K, Nishikawa Y, Tanaka I, Tanabe M.   +6 more
europepmc   +1 more source

AN EXPERIMENT OF MODIFIED COLLIS-NISSEN PROCEDURE FOR A CASE OF ESOPHAGEAL STENOSIS DUE TO GASTROESOPHAGEAL REFLUX DISEASE

, 2000
Toshihiro Inokuchi, Shinji Noshima, Chizuru Nakayashiki, Masakazu Fujii, Tetsuro Kobayashi, Tadahiko Enoki, Nobuya Zenpo, Kensuke Esato   +7 more
openalex   +2 more sources

Pantoprazole 40 and 20 mg prevents gastroesophageal reflux disease (GERD) relapse regardless of H. pylori status [PDF]

, 2000
Wieslaw Bochenek, Wilfred M. Weinstein, David C. Metz, David Miska   +3 more
openalex   +1 more source